Abstract
Our aim was to investigate whether combining two powerful antioxidants such as Trolox and quercetin could enhance their toxicity against breast and ovarian cancer cells. Human ovarian carcinoma cells from the A2780 line and human mammary gland carcinoma cells belonging to the T47Dkb-luc line were incubated in RPMI-1640 supplemented with 50 µM Trolox and various quercetin concentrations (25 µM, 50 µM and 100 µM). After 24 hours several test were conducted: cells were stained with trypan blue and the number of viable versus dead cells was counted; cells were stained with Hoechst 33258 and propidium iodide to investigate the incidence of apoptosis and necrosis and cell activity and proliferation was assessed using the MTT test. In the A2780 line 50 µM Trolox + 25µM quercetin increased the number of apoptotic cells and enzyme activity in these cells, without influencing viability. On the other hand, in the T47Dkb-luc line the 50 µM Trolox + 100 µM combination enhanced necrosis and thus reduced the percentages of metabolically active cells. Together with this concentration, a mix made of 50 µM Trolox and 25 µM quercetin also reduced cell viability. Our research indicates that in combination with Trolox low concentrations of quercetin induce apoptosis in human ovarian cancer cells while high concentrations induce necrosis in human breast cancer cells. Quercetin concentrations influence this response significantly. Combining quercetin with Trolox can enhance their toxicity against breast and ovarian cancer cells
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Bulletin of University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca. Animal Science and Biotechnologies
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.